Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Left ventricular assist system].

Shunei Kyo1, Motonobu Nishimura, Haruhiko Asano

  • 1Department of Cardio-Thoracic Surgery, Saitama Medical School, Saitama, Japan.

Nihon Geka Gakkai Zasshi
|October 22, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Successful Coil Embolization of a Giant Celiac Artery Aneurysm in a Patient With Liver Cirrhosis: A Case Report.

Cureus·2026
Same author

Identification of biomarkers to predict renal function decline and its deceleration in patients with type 2 diabetes and diabetic kidney disease.

Journal of diabetes and its complications·2025
Same author

FAM111B Suppression Enhances Sensitivity to Gemcitabine in Pancreatic Cancer Through Intracellular pH Regulation.

Cancer science·2025
Same author

Effect of heparin anticoagulation on the antithrombogenicity of an extracorporeal membrane oxygenation system under veno-arterial bypass in an animal model.

Heart and vessels·2025
Same author

Importance of gradual induction in oral anticoagulation therapy in a patient with heparin-induced thrombocytopenia with a left ventricular assist device: a case report.

General Thoracic and Cardiovascular Surgery Cases·2024
Same author

JCS/JSCVS/JCC/CVIT 2023 guideline focused update on indication and operation of PCPS/ECMO/IMPELLA.

Journal of cardiology·2024
Same journal

[MODIFIED BLUMGART SUTURING TECHNIQUE (NAGOYA METHOD) IN PANCREATICOJEJUNOSTOMY].

Nihon Geka Gakkai zasshi·2018
Same journal

[MODIFIED BLUMGART TECHNIQUE OF PANCREATOJEJUNOSTOMY（BLUMGART―DUMPLING METHOD)].

Nihon Geka Gakkai zasshi·2018
Same journal

[BLUMGART’S TYPE ANASTOMOSES;AN EMERGING TECHNIQUE FOR PANCREATICODUODENECTOMY].

Nihon Geka Gakkai zasshi·2018
Same journal

[WHAT WE CAN LEARN FROM A CASE OF MEDICAL MALPRACTICE―MEDICAL NEGLIGENCE CASE DISMISSED FOR INITIAL DIAGNOSIS OF BENIGN COLONIC POLYPS (THAT LATER TURNED CANCEROUS)].

Nihon Geka Gakkai zasshi·2018
Same journal

[WOUND CLOSURE METHODS FOR PREVENTION OF SURGICAL SITE INFECTION AND PATHOLOGIC SCARS－INCISION AND SUTURE METHODS FOR PREVENTION OF SSI, HYPERTROPHIC SCARS AND KELOID-].

Nihon Geka Gakkai zasshi·2018
Same journal

[PREFACE TO “WOUND CLOSURE METHODS FOR PREVENTION OF SURGICAL SITE INFECTION AND PATHOLOGIC SCARS ― INCISION AND SUTURE METHODS FOR PREVENTION OF SSI, HYPERTROPHIC SCARS AND KELOID ―”].

Nihon Geka Gakkai zasshi·2018
See all related articles

Artificial heart devices, including total artificial hearts (TAH) and ventricular assist systems (VAS), offer new hope for heart failure patients. Advances in VAS technology are improving quality of life and survival rates.

Area of Science:

  • Cardiovascular Medicine
  • Biomedical Engineering

Context:

  • End-stage heart failure necessitates advanced treatment options.
  • Artificial heart devices serve as crucial interventions for patients awaiting transplantation.
  • Ventricular Assist Systems (VAS) offer alternatives to heart transplantation.

Purpose:

  • To review the current state and advancements in artificial heart technology, specifically focusing on Ventricular Assist Systems (VAS).
  • To highlight the evolving role of VAS in managing end-stage heart failure, including bridge-to-transplantation, bridge-to-recovery, and semipermanent use.

Summary:

  • Two primary artificial heart types exist: Total Artificial Heart (TAH) and Ventricular Assist System (VAS).
  • VAS can support single or both ventricles, with paracorporeal and implantable options available.

Related Experiment Videos

  • Recent VAS advancements include improved quality of life, reduced costs, and innovative implantable systems like the Lion Heart.

    • Impact:

    • VAS therapy demonstrates superior clinical outcomes compared to conservative treatments, improving survival rates and quality of life.
    • Technological progress in VAS is expanding treatment possibilities for heart failure patients.
    • Development of cost-effective and fully implantable VAS is expected to further enhance patient care and accessibility.